Éric Baudin
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Thyroid Cancer Diagnosis and Treatment
- Pituitary Gland Disorders and Treatments
- Neurology top 0.1%
- Neuroblastoma Research and Treatments
Papers in
- Epidemiology 143
- Neuroendocrine Tumor Research Advances 143
-
- Thyroid Cancer Diagnosis and Treatment 91
- Pituitary Gland Disorders and Treatments 29
- Co-authors
- Martin Schlumberger (103 shared papers)Sophie Leboulleux (127 shared papers)Bernard Caillou (21 shared papers)Martin Schlumberger (35 shared papers)Michel Ducreux (62 shared papers)Dana M. Hartl (44 shared papers)Clarisse Dromain (38 shared papers)J. Lumbroso (37 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (34 papers)Journal of Clinical Oncology (25 papers)European Journal of Endocrinology (23 papers)Annals of Oncology (22 papers)European Journal of Cancer (14 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Éric Baudin
353 papers receiving 21.1k citations
Éric Baudin's Hit Papers
Peers
Comparison fields: 5 of 166
- Endocrinology, Diabetes and Metabolism 8.6k
- Neurology 4.5k
- Epidemiology 8.6k
- Oncology 6.0k
- Cancer Research 2.3k
Countries citing papers authored by Éric Baudin
This map shows the geographic impact of Éric Baudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Baudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Baudin more than expected).
Fields of papers citing papers by Éric Baudin
This network shows the impact of papers produced by Éric Baudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Baudin. The network helps show where Éric Baudin may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Baudin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 365 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial Hit paper breakdown → | 2011 | 1181 |
| 2 | Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study Hit paper breakdown → | 2011 | 805 |
| 3 | ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary Hit paper breakdown → | 2012 | 650 |
| 4 | Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial Hit paper breakdown → | 2009 | 519 |
| 5 | Genetic Testing in Pheochromocytoma or Functional Paraganglioma Hit paper breakdown → | 2005 | 510 |
| 6 | 2005 | 488 | |
| 7 | ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas Hit paper breakdown → | 2016 | 423 |
| 8 | 2007 | 395 | |
| 9 | 1999 | 383 | |
| 10 | 2007 | 361 | |
| 11 | 2007 | 329 | |
| 12 | ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging Hit paper breakdown → | 2017 | 323 |
| 13 | 1998 | 316 | |
| 14 | 2004 | 284 | |
| 15 | 2003 | 277 | |
| 16 | Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study Hit paper breakdown → | 2015 | 261 |
| 17 | 2000 | 261 | |
| 18 | 2014 | 257 | |
| 19 | 2013 | 256 | |
| 20 | 1990 | 248 |
About Éric Baudin
Éric Baudin is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Surgery, Oncology and Neurology, having authored 365 papers that have together received 21.8k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (143 papers), Thyroid Cancer Diagnosis and Treatment (91 papers), Neuroblastoma Research and Treatments (66 papers), Lung Cancer Research Studies (66 papers), Adrenal and Paraganglionic Tumors (62 papers), Cancer, Hypoxia, and Metabolism (34 papers), Pituitary Gland Disorders and Treatments (29 papers) and Thyroid and Parathyroid Surgery (24 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (8.6k citations), Neurology (4.5k citations), Epidemiology (8.6k citations), Oncology (6.0k citations) and Cancer Research (2.3k citations). Éric Baudin has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Martin Schlumberger, Sophie Leboulleux, Bernard Caillou, Martin Schlumberger, Michel Ducreux, Dana M. Hartl, Clarisse Dromain, J. Lumbroso, Jean‐Paul Travagli and Abir Al Ghuzlan. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology, European Journal of Endocrinology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.